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Purpose: In an effort to examine the clinicopathological characteristics of GC and the status of its surgical treatment, the Korean Gastric 
Cancer Association (KGCA) conducted a nationwide survey targeting surgically-treated gastric cancer patients in 2009.
Materials and Methods: A standardized electrical case report was sent to every member institution of the KGCA via E-mail with detailed 
instructions regarding the survey data. Completed data forms were retrieved from each institution and analyzed by the KGCA information 
committee.
Results: Data on 14,658 patients was collected from 59 institutions. The mean patient age was 59.2±11.9 years with a male to fe-
male ratio of 2.05 : 1. Lower third cancer (56.0%) was the most common among all gastric cancers. The histological type revealed 
poorly differentiated adenocarcinoma (34.1%) to be the most common, and the Lauren classification revealed the intestinal type (50.0%) 
to be the most prevalent. Curative surgery was performed in 92.4% of patients with laparoscopic surgery in 25.8% of patients. A Bill-
roth I reconstruction was performed most frequently after a distal gastrectomy (63.4% of distal gastrectomy). T1 cancers accounted for 
57.6% of all cases, and 62.6% of patients showed no lymph node metastasis. Compared to previous reports, it was found that patients 
are becoming older, laparoscopic surgery is being performed increasingly, and the proportion of T1 cancer is increasing with time. 
Conclusions: This survey presented the clinicopathological characteristics and current status of the surgical treatment of gastric cancer in 
Korea. This survey is expected aid research studies as well as planning and evaluation programs targeting cancer control.
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Introduction
Despite the decreasing global incidence, gastric cancer (GC) 
remains one of the most common forms of malignancy around the 
world.(1) GC is now the fourth most common malignancy after 
lung, breast, and colorectal cancer, and the second leading cause of 
cancer death worldwide. Furthermore, age-standardized incidence 
rates are twice as high for men.(2) GC is the fourth most com-
mon male cancer after lung, prostate, and colorectal cancer, and 
the fifth most common female cancer after breast, uterine cervix, 
colorectum, and lung cancer. The geographical distribution of GC 
is characterized by wide international variations. More than 70% 
of cases occur in developing countries, and half of the world’s case 
total occurs in Eastern Asia.(2) 
In South Korea, GC is now the most prevalent malignant neo-
plasm and annually affects over 25,000 patients. In addition, it is 
the second leading cause of cancer death after lung cancer, and is 
responsible for over 10,000 deaths per year.(3) Despite the publica-
tion of numerous single institutional experiences of GC, relatively 
little nationwide data is available that describes the demographic 
 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Jeong O and Park YK
70
and clinicopathological features of GC in Korea. Accurate statistics 
based on nationwide data are essential both for research and for the 
planning and evaluation of cancer control programs. In an effort 
to investigate the clinicopathological characteristics of GC and the 
status of its surgical treatment, the Korean Gastric Cancer Associa-
tion (KGCA) has conducted a nationwide survey targeting surgically 
treated gastric cancer patients every five years since 1999. The latest 
2004 nationwide survey results were published in 2007 after the first 
report was published in 2002.(4,5) Here, we present the results of a 
nationwide survey of 14,658 gastric cancer patients who were surgi-
cally treated for gastric cancer in 2009.
Materials and Methods
1. Survey data
In 1999, KGCA started a nationwide, hospital-based survey tar-
geting patients treated surgically for GC. This survey requested pa-
tients’ information regarding demographic and clinicopathological 
features and the surgical treatment administered at voluntarily par-
ticipating institutions. Patients that received treatments other than 
surgery, such as, endoscopic resection or systemic chemotherapy, 
were not included. Survey data included age, gender, resection type, 
reconstruction method, curability, surgical approach, tumor size, 
tumor location, macroscopic type, histologic type, Lauren’s classifi-
cation, tumor depth, presence of distant metastasis, and numbers of 
metastatic and harvested lymph nodes (Appendix 1). Histopatho-
logical characteristics are described according to the guidelines 
issued by the Korean Gastric Cancer Association.(6) For example, 
tumor locations were described as lower, middle, upper third, or 
whole stomach, and when a large tumor occupied more than two 
stomach regions, primary tumor site location was defined as the 
tumor center. Macroscopic gross types were classified as types I, 
IIa, IIb, IIc, or III for early gastric cancers, and as B1, B2, B3, or 
B4 for advanced gastric cancers. For combined superficial macro-
scopic types, the type occupying the largest area was recorded as 
the primary macroscopic type. Histologic types were classified as 
papillary adenocarcinoma, well differentiated, moderately differen-
tiated and poorly differentiated tubular adenocarcinoma, signet ring 
cell, and mucinous adenocarcinoma. Pathological staging, including 
tumor (T), node (N), and metastasis (M), was based on the sixth 
edition of the UICC TNM classification.(7) Surgical approaches 
were classified as either open or laparoscopic, and robotic assisted 
surgery was considered as laparoscopic surgery. 
2. Data collection and processing
A standardized electrical case report form prepared using spread 
sheet program (Microsoft Excel
Ⓡ) was sent to every member insti-
tution of the KGCA via E-mail with detailed instructions regard-
ing survey data. Completed data forms were retrieved from each 
institution and analyzed by the KGCA information committee. Re-
trieved data was reexamined for its correctness, for example, cor-
rect codes, and underwent a data validation process at the KGCA 
data center. During this process, if any question was raised about 
the data, an appropriate query was forwarded with the original data 
to the institution concerned. Data received on non-standard forms 
were converted into standardized format coded data. Missing values 
were either treated as ‘unknowns’ during the analysis of categorical 
data or were excluded from the analysis of continuous data. From 
February to April 2010, the KGCA information committee collect-
ed data from 59 institutions on 14,658 patients who had undergone 
surgery for GC during 2009.
3. Statistical analysis
Continuous data are presented as means and standard deviations, 
and were analyzed using the student’s t-test. The chi-square test was 
used to analyze categorical data. Statistical analyses were performed 
using SPSS for Windows ver. 12.0 (SPSS Inc., Chicago, IL, USA), 
and P-value of ＜0.05 were regarded statistically significant. 
Results
1. Institutions and patients
Fifty-nine institutions participated in the survey and data was 
collected on 14,658 patients, which represents a significant increase 
compared to the 29 institutions and 5,380 patients in the first survey 







Mean age (years, ±sd) 59.9±11.1 57.9±13.2 59.2±11.9
Age distribution (%)
   <30 years 54 (0.6) 80 (1.7)  134 (0.9)
   31~40 years 492 (5.0) 480 (9.9)  972 (6.6)
   41~50 years 1,537 (15.7) 955 (19.7) 2,493 (17.0)
   51~60 years 2,662 (27.1) 1,100 (22.7) 3,762 (25.7)
   61~70 years 3,271 (33.3) 1,256 (25.9) 4,528 (30.9)
   >70 years 1,800 (18.3) 968 (20.0) 2,769 (18.9)2009 Nationwide Survey of Gastric Cancer
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conducted in 1999. Of the 59 institutions, 23 institutions performed 
fewer than 100 operations, 18 institutions performed 100 to 200 
operations, and 12 institutions 200 to 500 operations. Six institutions 
performed more than 500 operations, and 44.8% of all GC surger-
ies were conducted at these six institutions in 2009.
2. Age and sex
Table 1 shows patients’ age and sex, and the distribution of 
patients according to age groups. There were 9,819 males and 
4,839 females with a mean age of 59.2±11.9 years. Male patients 
were significantly older than female patients (59.9 vs. 57.9 years, 
P＜0.001). For both sexes, the most common age was the sixth 
decade, which accounted for 30.9% of all cases, followed by the 
fifth decade (25.7%). Patients’ mean age has continued to increase 
for both sexes since the first survey conducted in 1995, and conse-
quently the proportion of patients aged ＞70 significantly increased 
from 9.1% in 1995 to 18.9% in 2009.(5)
The overall incidence of GC was as twice as high among men 
than women. However, when gender ratios were examined in age 
subgroups, the incidence of GC was found to be higher in women 
than in men in patient group aged ＜30 (male to female ratio of 1 : 
1.5). The proportion of male patients gradually increased with age 
and peaked in the sixth decade (male to female ratio of 2.6 : 1 in 
the sixth decade) (Table 1). 
2. Histopathological characteristics
Table 2 summarizes the histopathological characteristics of GCs. 
Tumors located in the lower third of the stomach were the most 
common and accounted for 56.0% of all cases. The percentages 
of tumors of the middle, upper, and whole stomach were 28.6%, 
13.4%, and 2.1%, respectively. When tumor location was investigat-
ed in age and sex subgroups, middle third cancers were found to be 
more common in younger patients and to decrease gradually with 
age from 46.7% in patients aged ＜30 to 23.3% in patients aged 
＞70 (Fig. 1). On the other hand, lower third cancers showed the 
opposite tendency and increased with age from 35.8% in patients 
aged ＜30 to 62.4% in patients aged ＞70. No significant difference 
was observed between men and women in terms of the distribution 
of tumor locations. 
Mean tumor diameter was 4.0±3.0 cm, and tumors with di-
ameters between 2 and 4 cm were most common. The mean 
number of retrieved lymph nodes per patient was 38±18. As for 
macroscopic type, Type IIc (56.6%) was the most prevalent gross 
type among early gastric cancers, followed by type IIb (20.3%). For 






   Lower third 7,919 56.0
   Middle third 4,045 28.6
   Upper third 1,895 13.4
   Whole stomach 292 2.1
Tumor maximal diameter (cm) 4.0±3.0
Retrieved lymph nodes 38±18
Size distribution
   <2 cm 3,063 22.0
   2~4 cm 5,212 37.5
   4~6 cm 2,821 20.3
   6~8 cm 1,437 10.3
   8~10 cm 673 4.8
   ≥10 cm  690 5.0
Macroscopic gross type
   I 400 3.0
   IIa 937 7.0
   IIb 1,578 11.7
   IIc 4,408 32.8
   III 462 3.4
   B 1 270 2.0
   B 2 1,235 9.2
   B 3 3,464 25.8
   B 4 679 5.1
Histologic type
   Papillary adenocarcinoma 168 1.2
   Tubular adenocarcinoma
      Well differentiated 1,761 12.5
      Moderately differentiated 4,283 30.3
      Poorly differentiated 4,820 34.1
   Signet ring cell carcinoma 2,681 19.0
   Mucinous carcinoma 324 2.3
   Others 100 0.7
Lauren’s classification
   Intestinal 3,699 50.0
   Diffuse 3,246 39.0
   Intermediate 771 10.9
*Unknown or missing values were excluded from the calculation of 
percentages.Jeong O and Park YK
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advanced gastric cancers, B3 (61.3%) type was the most common 
gross type, followed by B2 type (21.9%) (Fig. 2). 
Histologic classifications showed poorly differentiated adenocar-
cinoma was the most common histologic type and that it accounted 
for 34.1% of all cases. Lauren’s classification showed that the in-
testinal, diffuse and mixed types accounted for 50.0%, 39.0% and 
10.9%, respectively. When histologic type was compared between 
young and elderly patients (aged ＜40 vs. ≥40 years), the undiffer-
entiated type (poorly differentiated tubular adenocarcinoma, muci-
nous adenocarcinoma, and signet ring cell carcinoma) were found 
to be significantly more common in young than in elderly patients 
(86.1% vs. 53.9%, P＜0.001). Diffuse type carcinomas were also 
significantly more common in young patients (70.5% vs. 37.0%, P
＜0.001). 
3. Treatment details
Table 3 presents a summary of the operative procedures per-
formed. Of the 14,658 patients, 10,672 (72.8%) underwent open 
surgery and 3,783 (25.8%) laparoscopic surgery. Curative surgery 
was performed in 92.4% of patients. The number of laparoscopic 
surgeries showed a marked increase as compared with the 740 
cases (6.6% of all gastric cancer surgeries) encountered in 2004.
(5) As for resection types, 10,375 (70.8%) patients underwent distal 
gastrectomy and 3,248 (23.3%) total gastrectomy. Near total gas-
trectomy, proximal gastrectomy, pylorus preserving gastrectomy, 
and wedge resection were performed in 105 (0.7%), 141 (1.0%), 86 
(0.6%), and 51 (0.3%) patients, respectively. 
Table 4 details the reconstruction methods used after distal and 
total gastrectomy. The Billroth I procedure was most frequently 
performed after distal gastrectomy (in 63.4%), followed by Billroth 
II (33.1%). Roux-en-Y gastrojejunostomy was only performed in 
Fig. 1. Tumor location stratified by age (A) and sex (B). The proportion of middle third cancers gradually decreased with age, while that of lower 
third cancers increased (A). No significant differences were found between men and women in terms of tumor location (B).
Fig. 2. Macroscopic gross type in EGC 
(A) and in AGC (B). EGC = early gas-
tric cancer; AGC = advanced gastric 
cancer.2009 Nationwide Survey of Gastric Cancer
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3.3% of patients after distal gastrectomy. The most common recon-
struction procedure used after total gastrectomy was Roux-en-Y 
esophagojejunostomy, which was performed in 98.8% (3,308/3,348) 
of all total gastrectomy patients. Loop-esophagojejunostomy and 
jejunal interposition were performed in only in 18 (0.5%) and 10 
(0.3%) patients, respectively, after total gastrectomy. 
4. Tumor stage
Tumor stage, including tumor (T), node (N), and metastasis (M) 
stages, is illustrated in Table 5. As for the tumor depth, T1 cancers 
were the most common and accounted for 57.6% of cases, fol-
lowed by T2 (26.8%), T3 (12.8%), and T4 (2.8%). N stages showed 
N0, N1, N2, and N3 in 62.6%, 19.8%, 7.9% and 5.6% of patients, 
respectively. In the final TNM stages, there were IA, IB, II, IIIA, 
IIIB, and IV in 50.4%, 16.3%, 12.1%, 7.2%, 3.2%, and 10.8% of pa-
tients, respectively. Analysis of TNM stages by age or sex revealed 
no significant differences between the groups (Fig. 3).
When tumor stages in the serial cohorts of GC patients were 
compared, the proportion of T1 cancers was found to have in-
creased from 28.6% in 1995 to 57.7% in 2009. Similarly, the pro-
portion of node negative cancers was also found to have increased 






   R0 resection 13,537 92.4
   R1 resection 291 2.0
   R2 resection 257 1.8
   No resection 513 3.5
   Unknown 60 0.4
Operative approaches
   Open 10,672 72.8
   Laparoscopy 3,783 25.8
   Others 203 1.4
Resection type
   DG 10,375 70.8
   TG 3,348 23.3
   NTG 105 0.7
   PG 141 1.0
   PPG 86 0.6
   WR 51 0.3
   Bypass 196 1.3
   Exploration only 251 1.7
   Others 105 0.7
DG = distal gastrectomy; TG = total gastrectomy; NTG = near total 
gastrectomy; PG = proximal gastrectomy; PPG = pylorus preserving 
gastrectomy; WR = wedge resection.
Table 4. Reconstruction methods
Patients Percent (%)
Distal gastrectomy (N=10,375)
   Billroth I 6,581 63.4
   Billroth II 3,437 33.1
   Roux-en-Y 332 3.3
   Others 25 0.2
Total gastrectomy (N=3,348)
   Roux-en-Y 3,308 98.8
   Loop esophagojejunostomy 18 0.5
   Jejunal interposition 10 0.3
   Others 12 0.4






   T1 (mucosa) 4,507 31.9
   T1 (submucosa) 3,618 25.7
   T2 (proper muscle) 1,726 12.3
   T2 (subserosa) 2,038 14.5
   T3 (serosa exposure) 1,799 12.8
   T4 (organ invasion) 388 2.8
Nodal metastasis
   N0 9,176 62.6
   N1 2,900 19.8
   N2 1,165 7.9
   N3 792 5.6
Distant metastasis
   M1 788 5.5
TNM stages
   IA 7,127 50.4
   IB 2,306 16.3
   II 1,717 12.1
   IIIA 1,016 7.2
   IIIB 448 3.2
   IV 1,522 10.8
Tumor (T), node (N), and metastasis (M) were defined as described 
in the sixth edition of UICC TNM classification of gastric carcinoma. 
*Unknown or missing values were excluded from the calculation of 
percentages.Jeong O and Park YK
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from 49.3% in 1995 to 62.6% in 2009. Consequently, while the 
proportions of stage IA and IB patients has increased with time, the 
proportion of stage II or more patients has decreased. 
Discussion
GC is the most prevalent malignant neoplasm in South Korea 
and now accounts for about 16% of all cancer sites. According to 
the latest Korean cancer statistics, as of 2007, GC is the most com-
mon male cancer and the third most common female cancer after 
breast and thyroid cancer. Furthermore, GC is the third leading 
cause of cancer death after lung and liver cancer in men and the 
second leading cause of cancer death after lung cancer in women.
(3) Despite the continuing decline in the incidence of GC in the 
W est, the incidence of GC is higher in South Korea and Japan than 
in any other country, and this has remained unchanged over the 
past decade or more.(8) On the other hand, mortality due to GC 
continues to decrease in Korea, for example, the age-standardized 
mortality rate of GC decreased from 63 for men and 29 for women 
in the early 1980’s to 25 for men and 9 for women in 2007.(9) 
As has been widely reported, GC patients are getting older and 
the proportion of elderly patients continues to increase in South 
Korea.(10,11) A similar trend has also been observed in Japan.
(12) Our report showed that the mean age of GC patients was 59.2 
years and the proportion of patients aged ＞70 was as high as 19% 
in 2009, which is a substantial increase over the mean age of 55.5 
years and the proportion of patients aged ＞70 of 9% reported in 
1995.(4) However, the mean age of GC patients in South Korea 
and Japan is still younger than that reported in the W est, where the 
incidence of gastric cancer is much lower and nationwide screen-
ing program for GC is not performed.(13) Surgical treatment of 
elderly patients with GC requires comprehensive perioperative care, 
including the proper management of coexistent medical illnesses, 
which is essential to achieve optimal surgical outcomes. However, 
advances in operative techniques and perioperative care mean that 
chronologic age alone is no longer regarded as a crucial determi-
nant on deciding the surgical treatment.(14) 
The introduction of a national screening program in Korea for 
gastric cancer has resulted in the diagnosis of many gastric can-
cer patients with early stage disease.(15) In the present survey, the 
proportion of patients with early gastric cancer (EGC) was found 
to have markedly increased from 28.6% in 1995 to 57.7% in 2009. 
In addition to advances in treatment techniques, this early detection 
is believed to be primarily responsible for marked improvement 
in survival of GC in Korea and Japan.(16) With the excellent long 
term survival of EGC, treatment strategy for EGC is now moving 
to the direction of enhancing functional outcomes and postopera-
tive quality of life.(17) For example, laparoscopic surgery, function-
preserving surgery, and endoscopic resection provide good alter-
natives to radical surgery for the treatment of EGC. In a recent 
randomized trial, it was shown that laparoscopic surgery results in 
a better postoperative quality of life than open surgery in addition 
to short term benefits during the immediate postoperative period.
(18) Endoscopic resection is currently widely used to treat mucosal 
cancers without lymph node metastasis in Korea and Japan.(19) 
However, accurate preoperative diagnosis of tumor invasion extent 
and lymph node metastasis remain pivotal problems that must be 
adequately resolved to enable proper individualized treatments to be 
chosen for EGC patients. 
In the present study, tumors located in the lower third were 
Fig. 3. TNM stage according to age (A) and sex (B). TNM stage distributions were independent of age and sex.2009 Nationwide Survey of Gastric Cancer
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most common, and accounted for more than 50% of cases, where-
as the proportion of upper third cancers was the lowest at 13.4%. 
Contrary to the increasing incidence of distal esophageal adeno-
carcinoma and gastric cardia cancer in the W est, proximal GCs, 
including gastroesophageal junction (GEJ) cancers, are uncom-
mon in Korea, where most gastric cancers are located in the distal 
stomach.(20) Although the incidence of proximal GCs in 2009 was 
2.2% higher than in 1995, it is unclear whether upper GCs are truly 
increasing in Korea. In the literature, some authors have concluded 
that proximal GC shows an increasing trend in Korea,(10,11) but 
others disagree.(21) 
Some researchers have demonstrated clinicopathological differ-
ences of GC between young and old patients. In the present study, 
younger patients (＜40) contained larger proportions of females, 
middle third cancers, and undifferentiated and diffuse type carci-
nomas as compared with older patients (＞40). These age-related 
clinicopathological differences appear to sound because of the con-
sistency of the reports on the subject.(22,23) However, the causes of 
these differences are unclear, and investigations of these difference 
at the epidemiologic and molecular level are required to enhance 
our understanding of gastric carcinogenesis.
The standard surgery for gastric carcinoma is radical gastrec-
tomy with regional lymph node dissection, although the extent of 
lymph node dissection continues to be the subject of long standing 
debate. In Korea and Japan, D2 lymph node dissection is regarded 
as a standard surgery,(24) but the best form of reconstruction after 
distal gastrectomy has remained the subject of debate. Our survey 
showed that the most commonly performed reconstruction after 
distal gastrectomy is Billroth I reconstruction in Korea, which is 
probably because it is a simple and safe method to be performed 
using mechanical staplers. Gastrojejunostomy is often adopted 
when gastroduodenostomy is not technically feasible due concerns 
of anastomosis failure or the need for wide stomach resection. In 
Korea, Billroth II reconstruction is most widely used for gastrojeju-
nostomy, and Roux-en Y reconstruction is seldom performed. The 
best reconstruction method after distal gastrectomy remains to be 
determined because most studies on reconstruction after gastrec-
tomy have been small or non-randomized.(25) A large multicenter 
trial is required to compare the different reconstruction options 
after gastrectomy in terms of oncologic and physiologic functions. 
Summarizing, this survey describes the clinicopathological fea-
tures and surgical treatment of GC in Korea. Our survey showed 
that the number of elderly patients with GC has increased signifi-
cantly, as has the proportion of patient with EGC. Furthermore, 
laparoscopic surgery is being more widely used for the surgical 
treatment of EGC. The present study also presents the histopatho-
logical characteristics of GC in Korea, which can be compared with 
those of other countries. Finally, we hope that this survey will aid 
research studies and planning and evaluation programs that target 
cancer control. 
The Information Committee of  
the Korean Gastric Cancer Association
Information committee members are as follows: Oh Jeong, 
Y oung-K yu Park (Chonnam National University Hwasun Hospital, 
Hwasun, Korea), Jun Ho Lee (National Cancer Center), Ho Y oung 
Jeong (K yungpook National University), Jin Jo Kim (Catholic Uni-
versity Incheon St. Mary’s Hospital), Do Joong Park (Seoul Uni-
versity Bundang Hospital), Kab Joong Kim (Asan Medical Center).
Participating Institutions
The participating institutions are as follows: The Catholic Uni-
versity of Korea, Daejeon St. Mary’s Hospital; The Catholic Uni-
versity of Korea, St. Vincent’s Hospital; The Catholic University 
of Korea, Incheon St. Mary’s Hospital; The Catholic University of 
Korea, Seoul St. Mary’s Hospital; The Catholic University of Korea, 
Y eoido St. Mary’s Hospital; Konkuk University Medical Center; 
Konyang University Hospital; Kyungpook National University 
Hospital; Gyeongsang National University Hospital; Kyunghee 
University Medical Center; Keimyung University Dongsan Hos-
pital; Korea University Guro Hospital; Korea University Ansan 
Hospital; Kosin University Gospel Hospital; National Cancer Cen-
ter; National Medical Center; Daegu Catholic University Medical 
Center; Daegu Fatima Hospital; Saptist Hospital: Pusan National 
University Hospital; Pusan National University Y angsan Hospital; 
Pusan St. Mary’s Hospital; Busan Medical Center; Seoul National 
University Bundang Hospital; Daejin Medical Center; Bundang 
Cha Hospital; Samsung Medical Center; Seoul National University 
Hospital; Seoul National University Boramae Medical Center; Asan 
Medical Center; Seoul Medical Center; Handong University Sunlin 
Hospital; Saegyero Hospital; Soonchunhyang University Pucheon 
Hospital; Soonchunhyang University Cheonan Hospital; Ajou 
University Medical Center; Y eonsei University Severance Hospital; 
Y eonsei University Gangnam Severance Hospital; W onju Chris-
tian Hospital; Y eungnam University Medical Center; Presbyterian 
Medical Center; Dongkang Medical Center; W onkang University Jeong O and Park YK
76
Hospital; Korean Cancer Center Hospital; Ewha W oman’s Uni-
versity Mokdong Hospital; Inje University Dongnae Paik Hospital; 
Chonnam National University Hospital; Chonnam National Uni-
versity Hwasun Hospital; Chonbuk National University Hospital; 
Jeju National University Hospital; Chosun University Hospital; 
Chungang University Hospital; Chungang University Y ongsan 
Hospital; Chungnam National University Hospital; Chungbuk 
National University Hospital; Hallym University Medical Center; 
Hallym University Chuncheon Medical Center; Hallym University 
Hangang Medical Center; Hanyang University Hospital.
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Appendix 1. Survey data
Variables Descriptions
1. Institution Institution name
2. Age Years
3. Gender Male, female
4. Operation date yyyy-mm-dd
5. Resection types Distal gastrectomy, total gastrectomy, near-total gastrectomy, proximal gastrectomy, pylorus preserving 
gastrectomy, wedge resection, bypass surgery, exploration only, others 
6. Reconstructions Billroth-I, Billroth-II, Roux-en-Y esophagojejunostomy, loop esophagojejunostomy, jejunal interposition,  
Roux-en-Y gastrojejunostomy, others
7. Curability No residual tumor (R0), microscopic residual tumor (R1), macroscopic residual tumor (R2), no resection
8. Tumor size (cm) The largest tumor diameter
9. Tumor location Upper third, middle third, lower third, entire stomach
10. Macroscopic gross type I, IIa, IIb, IIc, III, B1, B2, B3, B4, others
11. Histologic types* Papillary, well differentiated tubular, moderately differentiated tubular, poorly differentiated tubular, mucinous, 
signet ring cell, others
12. Lauren’s classification Intestinal, diffuse, mixed
13. Tumor invasion
† Tx, Tis, T1 (m), T1 (sm), T2a (pm), T2b (ss), T3, T4
14. Nodal metastasis
† N0, N1, N2, N3
15. Distant metastasis
† M0, M1
16. Retrieved lymph nodes Numbers
17. Metastatic lymph nodes Numbers
18. Surgical approaches Open surgery, laparoscopic surgery, others
*WHO histologic classification of gastric cancer; 
†Based on the sixth edition of the UICC TNM classification of gastric carcinoma